Inventia Skin - Reinventing Skin Regeneration

 

Inventia Skin — 3D Bioprinting System for Intraoperative Skin Regeneration

Codename: Ligō from the Latin ‘to bind’

Robot that Prints New Skin could Revolutionise Burns Treatment

Inventia Life Science, world renowned skin surgeon and former Australian of the Year, Professor Fiona Wood, and leading bioprinting researcher, Professor Gordon Wallace, have received two major investments (MTPConnect BioMedTech Horizons & Medical Research Future Fund Stem Cell Therapies Mission) to accelerate the development of a robotic device that prints a patient’s own skin cells directly onto a burn or wound.


Inventia Skin’s Ligō robot prints tiny droplets containing patient’s skin cells + biomaterials to speed up the regenerative process and create a new layer of skin where it has been damaged. Ligō uses patented technology developed by Inventia Life Science featured in its RASTRUM™ platform for lab-based medical research and drug discovery.

The technology within Ligō enables rapid and precise delivery of multiple cell types and advanced biomaterials to a wound, providing the potential to recreate functional and aesthetically normal skin. A single procedure — reducing cost, hospital stays and minimising infection risks.

Aussie startup Inventia could revolutionize skin regeneration with 3D bioprinting robot

▶ READ MORE: BIOWORLD.COM

▶ READ MORE: PRWEB.COM

Founded in 2013, Inventia set out to create a bioprinter specifically for medical research. The Inventia team worked with Design + Industry on the RASTRUM™ Technology + Design + Development. In 2019 RASTRUM took out two top awards - winning both the prestigious Good Design Award of the Year + the Best in Class Award for the medical and scientific product category. RASTRUM™ was recognised by Fast Company - Winning the 2020 World Changing Ideas Award (Experimental Category).

 
Bart2020